Accession Therapeutics
- Biotech or pharma, therapeutic R&D
Creating the ideal immunotherapy which provides potent tumour-selective delivery and tumour-selective killing ability through IV delivery. Lead program has entered the clinic 2025.
Address
OxfordOxfordshire
United Kingdom
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}